References
- Abdalla, A. A. R. K., Mohamed, A. M. A. (2014). Prevalence of extended spectrum β-lactamase producing Klebsiella pneumonia in clinical isolates. Jundishapur J. Microbiol., 7, 1-5.
- Anonymous (2013). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_v1.0_20131211.pdf (acessed 19.06.2016).
- Anonymous (2015). WHO. International statistical classification of diseases and related health problems. ICD-10 Version. Available at: http://apps.who.int/classifications/icd10/browse/2015/en (accessed 19.06.2016).
- Concepts, C., Peleg, A. Y., Hooper, D. C. (2010). Hospital-acquired infections due to gram-negative bacteria. New Engl. J. Med., 362, 1804-1813.
- Du, B., An, Y., Kang, Y., Yu, X., Zhao, M., Ma, X., Ai, Y., Xu, Y., Wang, Y., Qian, C., Wu, D., Sun, R., Li, S., Hu, Z., Cao, X., Zhou, F., Jiang, L., Lin, J., Chen, E., Qin, T., He, Z., Zhou, L. (2013). Characteristics of critically ill patients in ICUs in mainland China. Crit. Care Med., 41, 84-92.
- Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., Stratchounski, L. (2003). Prevalence and molecular epidemiology of CTX-M extended-spectrumlactamase- producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents. Chemother., 47, 3724-3732.
- Kim, B. N., Woo, J. H., Kim, M. N., Ryu, J., Kim, Y. S. (2002). Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J. Hosp. Infect., 52, 99-106.
- Mayr, V. D., Dünser, M. W., Greil, V., Jochberger, S., Luckner, G., Ulmer, H., Friesenecker, B. E., Takala, J., Hasibeder, W. R. (2006). Causes of death and determinants of outcome in critically ill patients. Crit. Care, 10 (6), R154.
- Mehrgan, H., Rahbar, M., Arab-halvaii, Z. (2010). High prevalence of extended- spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran. Iran J. Infect. Dev. Ctries., 4 (3), 132-138.
- Nüesch-Inderbinen, M. T., Hächler, H., Kayser, F. H. (1996). Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis., 15, 398-402.
- Peralta, G., Lamelo, M., Alvarez-García, P., Velasco, M., Delgado, A., Horcajada, J. P., Montero, M., Pia Roiz, M., Farinas, M. C., Alonso, J., Martinez, L. M., Gutierrez-Macias, A., Alava, J. A., Rodríguez, A., Fleites, A., Navarro, V., Sirvent, E., Capdevila, J. A. (2012). Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect. Dis., 12, 245-251.
- Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., Kamal, M. A. (2015). Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. Biol. Sci., 22, 90-101.
- Skippen, I., Shemko, M., Turton, J., Kaufmann, M. E., Palmer, C., Shetty, N. (2006). Epidemiology of infections caused by extended-spectrum _-lactamase-producing Escherichia coli and Klebsiella spp.: A nested case-control study from a tertiary hospital in London. J. Hosp. Infect., 64, 115-23.
- Spanu, T., Luzzaro, F., Perilli, M., Amicosante, G., Toniolo, A., Fadda, G. (2002). Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob. Agents Chemother., 46, 196-202.
- Thu Trang, N. H., Thieu Nga, T. V., Campbell, J. I., Hiep, N. T., Farrar, J., Baker, S., Duy, P. T. (2013). The characterization of ESBL genes in Escherichia coli and Klebsiella pneumoniae causing nosocomial infections in Vietnam. J. Infect. Dev. Ctries., 7, 922-928.
- Wu, T. L., Siu, L. K., Su, L. H., Lauderdale, T. L., Lin, F. M., Leu, H. S., Lin, T. Y., Ho, M. (2001). Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J. Antimicrob. Chemother., 47, 755-761.
- Wu, Y. H., Chen, P. L., Hung, Y. P., Ko, W. C. (2014). Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J. Microbiol. Immunol. Infect., 47, 197-203.